Optiscan Imaging Limited Logo

Optiscan Imaging Limited

OIL.AX

(0.5)
Stock Price

0,16 AUD

-103.07% ROA

-55.98% ROE

-11.84x PER

Market Cap.

66.914.682,00 AUD

13.54% DER

0% Yield

-323.87% NPM

Optiscan Imaging Limited Stock Analysis

Optiscan Imaging Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Optiscan Imaging Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (8%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-50.75%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-56.61%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's elevated P/BV ratio (9.85x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Optiscan Imaging Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Optiscan Imaging Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Optiscan Imaging Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Optiscan Imaging Limited Revenue
Year Revenue Growth
1997 0
1998 0 0%
1999 0 0%
2000 137.426 100%
2001 407.000 66.23%
2002 6.244.334 93.48%
2003 2.434.700 -156.47%
2004 1.066.962 -128.19%
2005 3.232.015 66.99%
2006 5.707.536 43.37%
2007 1.840.649 -210.08%
2008 2.887.626 36.26%
2009 1.233.748 -134.05%
2010 1.776.954 30.57%
2011 381.791 -365.43%
2012 1.303.345 70.71%
2013 71.883 -1713.15%
2014 46.092 -55.96%
2015 309.697 85.12%
2016 1.333.263 76.77%
2017 2.185.579 39%
2018 1.041.679 -109.81%
2019 1.191.853 12.6%
2020 1.190.712 -0.1%
2020 889.526 -33.86%
2021 1.013.039 12.19%
2022 3.073.624 67.04%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Optiscan Imaging Limited Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 2.487.616 100%
2001 3.110.659 20.03%
2002 4.355.860 28.59%
2003 3.820.657 -14.01%
2004 3.258.749 -17.24%
2005 3.121.821 -4.39%
2006 3.677.808 15.12%
2007 3.482.509 -5.61%
2008 2.622.937 -32.77%
2009 1.509.047 -73.81%
2010 1.022.883 -47.53%
2011 1.192.243 14.21%
2012 1.519.404 21.53%
2013 1.255.457 -21.02%
2014 1.070.373 -17.29%
2015 1.265.884 15.44%
2016 2.207.786 42.66%
2017 1.974.733 -11.8%
2018 703.784 -180.59%
2019 1.612.052 56.34%
2020 1.612.052 0%
2020 1.666.265 3.25%
2021 2.165.035 23.04%
2022 2.798.120 22.63%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Optiscan Imaging Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 2.273.204 100%
2001 2.865.676 20.67%
2002 3.141.075 8.77%
2003 2.653.657 -18.37%
2004 3.257.304 18.53%
2005 3.357.402 2.98%
2006 3.303.797 -1.62%
2007 2.980.166 -10.86%
2008 2.235.769 -33.29%
2009 1.651.388 -35.39%
2010 1.117.563 -47.77%
2011 1.854.625 39.74%
2012 1.524.590 -21.65%
2013 1.021.804 -49.21%
2014 1.315.783 22.34%
2015 1.331.357 1.17%
2016 2.359.991 43.59%
2017 2.281.135 -3.46%
2018 1.721.005 -32.55%
2019 1.322.718 -30.11%
2020 1.322.718 0%
2020 1.670.208 20.81%
2021 1.645.808 -1.48%
2022 1.263.556 -30.25%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Optiscan Imaging Limited EBITDA
Year EBITDA Growth
1997 -1.551.001
1998 -1.323.007 -17.23%
1999 -2.655.000 50.17%
2000 -4.009.000 33.77%
2001 -7.129.000 43.76%
2002 -2.423.832 -194.12%
2003 -4.464.927 45.71%
2004 -6.787.926 34.22%
2005 -6.224.040 -9.06%
2006 -5.803.804 -7.24%
2007 -6.595.502 12%
2008 -2.942.942 -124.11%
2009 -2.676.668 -9.95%
2010 -663.580 -303.37%
2011 -2.976.068 77.7%
2012 -2.177.111 -36.7%
2013 -2.281.129 4.56%
2014 -1.272.238 -79.3%
2015 -2.395.474 46.89%
2016 -2.828.621 15.31%
2017 -1.904.188 -48.55%
2018 -2.512.322 24.21%
2019 -1.464.254 -71.58%
2020 -1.464.254 0%
2020 -1.832.141 20.08%
2021 -3.960.325 53.74%
2022 -3.663.936 -8.09%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Optiscan Imaging Limited Gross Profit
Year Gross Profit Growth
1997 0
1998 0 0%
1999 0 0%
2000 35.632 100%
2001 201.773 82.34%
2002 6.188.886 96.74%
2003 2.427.208 -154.98%
2004 277.957 -773.23%
2005 776.706 64.21%
2006 1.756.680 55.79%
2007 733.393 -139.53%
2008 714.729 -2.61%
2009 704.778 -1.41%
2010 1.489.354 52.68%
2011 245.751 -506.04%
2012 939.542 73.84%
2013 34.193 -2647.76%
2014 33.257 -2.81%
2015 214.871 84.52%
2016 826.807 74.01%
2017 1.593.696 48.12%
2018 -64.202 2582.32%
2019 302.226 121.24%
2020 1.190.712 74.62%
2020 -410.138 390.32%
2021 -2.685.908 84.73%
2022 -1.770.184 -51.73%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Optiscan Imaging Limited Net Profit
Year Net Profit Growth
1997 -1.571.000
1998 -1.343.000 -16.98%
1999 -2.671.000 49.72%
2000 -4.690.000 43.05%
2001 -2.504.000 -87.3%
2002 -3.426.015 26.91%
2003 0 0%
2004 -5.830.434 100%
2005 -3.936.760 -48.1%
2006 -2.139.481 -84.01%
2007 -4.984.340 57.08%
2008 -6.413.370 22.28%
2009 -1.650.799 -288.5%
2010 14.405 11559.9%
2011 -2.502.450 100.58%
2012 -643.950 -288.61%
2013 -1.417.712 54.58%
2014 -1.395.399 -1.6%
2015 -1.337.056 -4.36%
2016 -2.942.925 54.57%
2017 -2.035.328 -44.59%
2018 -2.344.119 13.17%
2019 -1.765.353 -32.78%
2020 -1.765.353 0%
2020 -2.126.695 16.99%
2021 -4.233.037 49.76%
2022 -3.968.792 -6.66%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Optiscan Imaging Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Optiscan Imaging Limited Free Cashflow
Year Free Cashflow Growth
1997 -108.000
1998 -320.000 66.25%
1999 -393.000 18.58%
2000 -4.793.412 91.8%
2001 460.874 1140.07%
2002 -546.862 184.28%
2003 -5.495.782 90.05%
2004 -4.315.279 -27.36%
2005 -5.085.423 15.14%
2006 -2.445.241 -107.97%
2007 -4.650.662 47.42%
2008 -3.310.201 -40.49%
2009 -1.230.248 -169.07%
2010 -487.719 -152.25%
2011 -822.321 40.69%
2012 -1.223.818 32.81%
2013 -683.392 -79.08%
2014 -1.474.151 53.64%
2015 -512.003 -187.92%
2016 -3.594.013 85.75%
2017 -290.523 -1137.08%
2018 -1.425.304 79.62%
2019 -1.416.749 -0.6%
2020 -2.157.175 34.32%
2021 -3.957.714 45.49%
2022 -988.740 -300.28%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Optiscan Imaging Limited Operating Cashflow
Year Operating Cashflow Growth
1997 0
1998 0 0%
1999 0 0%
2000 -4.073.412 100%
2001 1.246.874 426.69%
2002 -331.947 475.62%
2003 -5.129.978 93.53%
2004 -4.001.422 -28.2%
2005 -4.810.970 16.83%
2006 -1.882.270 -155.59%
2007 -4.094.939 54.03%
2008 -3.189.129 -28.4%
2009 -1.227.864 -159.73%
2010 -468.579 -162.04%
2011 -793.545 40.95%
2012 -1.193.270 33.5%
2013 -683.392 -74.61%
2014 -1.459.644 53.18%
2015 -509.246 -186.63%
2016 -3.412.811 85.08%
2017 0 0%
2018 -1.420.797 100%
2019 -1.396.563 -1.74%
2020 -2.126.309 34.32%
2021 -3.833.578 44.53%
2022 -986.413 -288.64%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Optiscan Imaging Limited Capital Expenditure
Year Capital Expenditure Growth
1997 108.000
1998 320.000 66.25%
1999 393.000 18.58%
2000 720.000 45.42%
2001 786.000 8.4%
2002 214.915 -265.73%
2003 365.804 41.25%
2004 313.857 -16.55%
2005 274.453 -14.36%
2006 562.971 51.25%
2007 555.723 -1.3%
2008 121.072 -359%
2009 2.384 -4978.52%
2010 19.140 87.54%
2011 28.776 33.49%
2012 30.548 5.8%
2013 0 0%
2014 14.507 100%
2015 2.757 -426.19%
2016 181.202 98.48%
2017 290.523 37.63%
2018 4.507 -6346.04%
2019 20.186 77.67%
2020 30.866 34.6%
2021 124.136 75.14%
2022 2.327 -5234.59%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Optiscan Imaging Limited Equity
Year Equity Growth
1997 7.737.408
1998 6.894.401 -12.23%
1999 17.493.537 60.59%
2000 13.181.519 -32.71%
2001 19.597.066 32.74%
2002 16.183.369 -21.09%
2003 12.899.916 -25.45%
2004 13.381.323 3.6%
2005 10.313.494 -29.75%
2006 9.933.167 -3.83%
2007 7.703.514 -28.94%
2008 1.757.167 -338.41%
2009 1.300.262 -35.14%
2010 1.342.714 3.16%
2011 313.310 -328.56%
2012 952.456 67.11%
2013 -184.662 615.78%
2014 -175.211 -5.39%
2015 -749.650 76.63%
2016 1.665.359 145.01%
2017 3.201.425 47.98%
2018 2.823.803 -13.37%
2019 1.548.323 -82.38%
2020 10.217.106 84.85%
2021 6.592.409 -54.98%
2022 3.044.436 -116.54%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Optiscan Imaging Limited Assets
Year Assets Growth
1997 8.396.766
1998 8.036.232 -4.49%
1999 18.254.080 55.98%
2000 13.655.178 -33.68%
2001 22.043.957 38.05%
2002 19.317.634 -14.11%
2003 13.715.461 -40.85%
2004 14.419.011 4.88%
2005 11.977.822 -20.38%
2006 11.604.304 -3.22%
2007 9.230.080 -25.72%
2008 2.876.396 -220.89%
2009 2.192.401 -31.2%
2010 2.199.650 0.33%
2011 1.180.671 -86.31%
2012 1.510.433 21.83%
2013 816.352 -85.02%
2014 1.018.211 19.82%
2015 1.820.836 44.08%
2016 2.666.718 31.72%
2017 4.130.119 35.43%
2018 3.644.445 -13.33%
2019 3.444.887 -5.79%
2020 11.696.673 70.55%
2021 7.984.102 -46.5%
2022 4.671.971 -70.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Optiscan Imaging Limited Liabilities
Year Liabilities Growth
1997 659.358
1998 1.141.831 42.25%
1999 760.543 -50.13%
2000 473.659 -60.57%
2001 2.446.891 80.64%
2002 3.134.265 21.93%
2003 815.545 -284.32%
2004 1.037.688 21.41%
2005 1.664.328 37.65%
2006 1.671.137 0.41%
2007 1.526.566 -9.47%
2008 1.119.229 -36.39%
2009 892.139 -25.45%
2010 856.936 -4.11%
2011 867.361 1.2%
2012 557.977 -55.45%
2013 1.001.014 44.26%
2014 1.193.422 16.12%
2015 2.570.486 53.57%
2016 1.001.359 -156.7%
2017 928.694 -7.82%
2018 820.642 -13.17%
2019 1.896.564 56.73%
2020 1.479.567 -28.18%
2021 1.391.693 -6.31%
2022 1.627.535 14.49%

Optiscan Imaging Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.01
Price to Earning Ratio
-11.84x
Price To Sales Ratio
25.56x
POCF Ratio
-16.27
PFCF Ratio
-20.33
Price to Book Ratio
16.92
EV to Sales
25.38
EV Over EBITDA
-16.08
EV to Operating CashFlow
-21
EV to FreeCashFlow
-20.19
Earnings Yield
-0.08
FreeCashFlow Yield
-0.05
Market Cap
0,07 Bil.
Enterprise Value
0,07 Bil.
Graham Number
0.03
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.73
ROE
-1.87
Return On Assets
-0.3
Return On Capital Employed
-0.39
Net Income per EBT
0.89
EBT Per Ebit
0.95
Ebit per Revenue
-3.79
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
0.48
Research & Developement to Revenue
0.93
Stock Based Compensation to Revenue
0.09
Gross Profit Margin
-0.52
Operating Profit Margin
-3.79
Pretax Profit Margin
-3.62
Net Profit Margin
-3.24

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0.04
Capex to Revenue
-0.05
Capex to Depreciation
-0.33
Return on Invested Capital
-1.14
Return on Tangible Assets
-1.03
Days Sales Outstanding
136.07
Days Payables Outstanding
48.85
Days of Inventory on Hand
133.9
Receivables Turnover
2.68
Payables Turnover
7.47
Inventory Turnover
2.73
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0.14
Debt to Assets
0.09
Net Debt to EBITDA
0.11
Current Ratio
2.56
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.14
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
1437471
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Optiscan Imaging Limited Dividends
Year Dividends Growth

Optiscan Imaging Limited Profile

About Optiscan Imaging Limited

Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

CEO
Prof. Camile Farah M.A.I.C.D.
Employee
8
Address
16 Miles St
Mulgrave, 3170

Optiscan Imaging Limited Executives & BODs

Optiscan Imaging Limited Executives & BODs
# Name Age
1 Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D.
Chief Executive Officer, MD & Executive Director
70
2 Mr. Brendan Fafiani
Chief Operating Officer
70
3 Mr. Justin Mouchacca B.Bus (Acc), C.A., CA
Company Secretary
70

Optiscan Imaging Limited Competitors

Compumedics Limited Logo
Compumedics Limited

CMP.AX

(1.5)
IDT Australia Limited Logo
IDT Australia Limited

IDT.AX

(1.2)
Patrys Limited Logo
Patrys Limited

PAB.AX

(1.0)
Uscom Limited Logo
Uscom Limited

UCM.AX

(1.0)